Contact this trialFirst, we need to learn more about you.
Glucagon-Like Peptide-1 Receptor Agonist
Semaglutide for Obesity-Related Asthma
Recruiting0 awardsPhase 2
Nashville, Tennessee
This trial will test whether semaglutide, an FDA-approved diabetes and obesity drug, can improve asthma control in adults who are overweight and not well-controlled with inhaled steroids.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.